ArticleHemaSphere2020
MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease.
Inga Hegemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleHemaSphere2020
Inga Hegemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.